HOME >> BIOLOGY >> NEWS
How long is a child a child?

With an innovative combination of a novel application of synchrotron imaging, high-resolution microtomography, and developmental analysis, the team reconstructed tooth growth and determined the age at death of a fossil juvenile from Jebel Irhoud, Morocco. This study represents the first non-destructive approach to characterize dental development with a high degree of precision, as synchrotron images reveal microscopic internal growth lines without damage to the specimen. The team found that the Moroccan fossil child showed an equivalent degree of tooth development to living human children at the same age. These findings and other evidence suggest that modern biological, behavioural, and cultural characteristics appeared relatively late in the past six million years of human evolution.

Modern human origins continues to be one of the most hotly debated topics among anthropologists, and there is little consensus about where and when the first members of our species, Homo sapiens, became fully modern. While fossil evidence tells a complex tale of mosaic change during the African Stone Age, almost nothing is known about changes in human life history, or the timing of development, reproductive scheduling, and lifespan. Tooth growth, and most importantly molar tooth eruption age, represents one of the most powerful clues to reconstruct growth processes in fossil humans. By using incremental growth lines in teeth, similar to annual rings in trees, developmental rate and time may be accurately established millions of years after death. Research during the past two decades has shown that early fossil humans (australopithecines and early Homo) possessed short growth periods, which were more similar to chimpanzees than to living humans. However, it unclear when, in and which group of fossil humans, the modern condition of a relatively long childhood arose.

In this study, tooth growth and eruption was examined in one of the earliest representatives of Ho
'"/>

Contact: Sandra Jacob
jacob@eva.mpg.de
49-341-355-0122
Max-Planck-Gesellschaft
13-Mar-2007


Page: 1 2

Related biology news :

1. Adult survivors of childhood leukemia exercise less, worsening high risk for obesity and illness
2. Gene identified for Crohns disease in children
3. Gene discovered for type 1 diabetes in children
4. Key to tackling malaria may lie in bed nets for adults and older children
5. Gene variant increases risk for alcoholism following childhood abuse
6. Cord blood may preserve insulin levels in children with type 1 diabetes
7. Researchers isolate new risk marker for overweight children
8. Study suggests other causes for childhood brain aneurysms
9. Study shows lizard moms dress their children for success
10. Lucky 13 as new gene discovery offers further hope for childhood blindness
11. Call of the child

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: How long child child

(Date:10/16/2014)... Cancer constantly wages war on the human body. ... a stalemate. In pancreatic cancer, this stalemate—known as ... becoming aggressively malignant, a phenomena that is poorly ... in the laboratory of Salvatore Torquato, a Professor ... the conditions surrounding tumor dormancy and the switch ...
(Date:10/16/2014)... cultivated efficiently, they are anything but sustainable: environmental ... cultivation is becoming increasingly evident. Despite their disadvantages, ... are regarded as the sole possibility of achieving ... finds Bernhard Schmid, an ecology professor at the ... of agriculture and forestry. After all, a new ...
(Date:10/15/2014)... , Oct. 15, 2014 Sandata Technologies, ... home and community-based care, today announced it released ... Sandata,s Santrax® Electronic Visit Verification™ Solution (EVV™)  for ... a home health company founded in 1996 and ... . The study details the ...
Breaking Biology News(10 mins):Modeling tumor dormancy 2Plant communities produce greater yield than monocultures 2Plant communities produce greater yield than monocultures 3Sandata Announces Case Study with Quality Care Services, Inc. 2
(Date:10/22/2014)... , Oct. 22, 2014 Nuvilex, Inc. ... approximately 400 million people worldwide are living with diabetes, ... people by 2030.  The global market for diabetes treatments ... approximately 330,000 people worldwide died from pancreatic cancer.  Pancreatic ... due to cancer in the United States ...
(Date:10/20/2014)... The report “Pharmacy Automation Systems Market ... Labeling Systems, Table-top Counters) by End-user (Inpatient Pharmacy ... Trends to 2019” analyzes and studies the major ... Europe, Asia-Pacific, and the Rest of the World ... figures spread through 300 pages and in-depth TOC ...
(Date:10/20/2014)... PARK, Calif. , Oct. 20, 2014 /PRNewswire/ ... today that the Company has signed a Notice ... of Regenerative Medicine (CIRM), effective October 1, 2014.  ... Clinical Development payments and the release of additional ... million CIRM grant award for clinical development of ...
(Date:10/20/2014)... Md. , Oct. 20, 2014  GenVec, Inc. (NASDAQ: ... Zola P. Horovitz , Ph.D., from its board of directors ... board in August 2003, and served as its chairman from ... served on the Nominating and Corporate Governance and Audit Committees ... for more than a decade of dedicated service to GenVec, ...
Breaking Biology Technology:Nuvilex Brief Analyst Report: Thinking Outside the Box by BrokerBank Securities, Inc. 2Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 2Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 3Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 4Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 4Zola P. Horovitz To Retire From GenVec Board 2
Cached News: